Found 7 matching trials
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC) PHASE2 This will be a randomised, crossover, double-blind, double-dummy, active-co...
Show More Location
Clinical Research Services Turku CRST
Learn More & Join Trial
Levodopa Concentration Profile With Stalevo 75/125 mg PHASE1 The purpose of this study is to confirm that the dose levels and dosing fre...
Show More Location
Phase I Unit, Orion Pharma
Learn More & Join Trial
Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens PHASE2 The primary objective is to assess the effect of a single dose of two exper...
Show More Location
Kanta-Hämeen keskussairaala
Learn More & Join Trial
Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease NA The purpose of this study is to investigate the genetic variants of clock a...
Show More Location
Asan Medical Center
Learn More & Join Trial
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off PHASE4 The purpose of this study is to test the effects of carbidopa/levodopa/enta...
Show More Learn More & Join Trial
Study to Evaluate Initiation of Stalevo in Early Wearing-off PHASE4 An open, non-randomised, multinational, multicentre direct switch study in ...
Show More Location
Humboldt Universität Charité Neurologische Klinik
Learn More & Join Trial
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations PHASE2 The primary objective of the study is to assess the efficacy, carbidopa dos...
Show More Location
Multiple Locations
Learn More & Join Trial